Suchergebnisse - "Peng, Cheng-Yuan"

PubPharm (294)

1

Four weeks of off-treatment follow-up is sufficient to determine virologic responses at off-treatment week 12 in patients with hepatitis C virus infection receiving fixed-dose pangenotypic direct-acting antivirals

enthalten in: Journal of medical virology | 2024

von Liu, C. | Chang, Y. | Lee, J. | +14

2

Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan

enthalten in: Infectious diseases and therapy | 2024

von Yang, C. | Huang, C. | Chang, T. | +41

3

Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy

enthalten in: Clinical and molecular hepatology | 2024

von Tsai, P. | Huang, C. | Yeh, M. | +38

4

Dynamic change of metabolic dysfunction-associated steatotic liver disease in patients with hepatitis C virus infection after achieving sustained virologic response with direct-acting antivirals

enthalten in: Journal of gastroenterology | 2024

von Liu, C. | Chang, Y. | Fang, Y. | +14

5

An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan

enthalten in: Hepatology international | 2024

von Yu, M. | Tai, C. | Mo, L. | +42

6

Phase 1 Trial of the Safety, Pharmacokinetics, and Antiviral Activity of EDP-514 in Untreated Viremic Chronic Hepatitis B Patients

enthalten in: Clinical and molecular hepatology | 2024

von Yuen, M. | Chuang, W. | Peng, C. | +9

7

The influence of resolution on the predictive power of spatial heterogeneity measures as biomarkers of liver fibrosis

enthalten in: Computers in biology and medicine | 2024

von Claes, J. | Agten, A. | Blázquez-Moreno, A. | +7

8

Liver stiffness and spleen stiffness predict distinct liver-related events after hepatitis C eradication with direct-acting antivirals

enthalten in: Journal of the Formosan Medical Association = Taiwan yi zhi | 2024

von Chen, S. | Lai, H. | Su, W. | +5

9

Four weeks of off-treatment follow-up is sufficient to determine virologic responses at off-treatment week 12 in patients with hepatitis C virus infection receiving pangenotypic direct-acting antivirals

enthalten in: ResearchSquare.com | 2024

von Liu, C. | Chang, Y. | Lee, J. | +14

10

Chronic hepatitis B baseline viral load and on-treatment liver cancer risk : A multinational cohort study of HBeAg-positive patients

enthalten in: Hepatology (Baltimore, Md.) | 2024

von Choi, W. | Yip, T. | Kim, W. | +18

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[30]